Lenny felt great after finishing chemotherapy for his non-Hodgkin lymphoma in 2009. But when the cancer returned three years later, his doctor, medical oncologist Paul Hamlin, Chief of Medical Oncology at Memorial Sloan Kettering’s outpatient facility in Basking Ridge, New Jersey, recommended that he join a clinical trial testing a promising new therapy for lymphoma.
As Dr. Hamlin explains, clinical trials offer a rigorous, scientific way to compare the ‘standard of care’ with promising new therapies. “The treatments we call standard of care today were the clinical trials of a few years ago, and that’s how we move forward.”
For Lenny, the experimental therapy proved a highly effective treatment. He also had the satisfaction of knowing his experience could help another patient down the road.